Financial Performance - The company's operating revenue for the first half of 2022 was approximately RMB 290.68 million, a decrease of 21% compared to RMB 367.94 million in the same period last year[17]. - The net profit attributable to shareholders of the listed company was a loss of approximately RMB 29.48 million, compared to a loss of RMB 10.61 million in the same period last year[17]. - The basic earnings per share for the first half of 2022 was a loss of RMB 0.0536, compared to a loss of RMB 0.0193 in the same period last year[18]. - The weighted average return on net assets was -1.39%, compared to -0.50% in the previous year[18]. - The company reported a total comprehensive income for the first half of 2022 was a loss of CNY 29,738,779.18, compared to a loss of CNY 10,127,007.66 in the first half of 2021, indicating a significant decline in overall performance[107]. - The total profit for the first half of 2022 was a loss of CNY 37,629,326.80, compared to a loss of CNY 18,207,828.91 in the same period of 2021, representing an increase in loss of approximately 106.5%[106]. Cash Flow and Investments - The net cash flow from operating activities was a negative RMB 13.68 million, an improvement from a negative RMB 39.03 million in the previous year[17]. - The net cash flow from investment activities showed a significant outflow of 21.04 million yuan, primarily due to participation in CITIC Securities' rights issue[41]. - The company reported a fair value loss of 31.72 million yuan, significantly impacting profits due to fluctuations in the market value of stocks held, particularly in CITIC Securities[42]. - Cash inflow from investment activities increased to 39,015,943.35 RMB, up 27% from 30,671,790.09 RMB in the same period last year[109]. - Cash outflow from investment activities rose to 60,051,235.12 RMB, a significant increase of 68% compared to 35,576,729.24 RMB in the first half of 2021[109]. Assets and Liabilities - The total assets at the end of the reporting period were approximately RMB 2.49 billion, down 1.49% from RMB 2.52 billion at the end of the previous year[18]. - The total liabilities amounted to CNY 386,724,929.47, a slight decrease from CNY 394,485,360.45 at the beginning of the year[96]. - Total current assets as of June 30, 2022, amounted to CNY 1,753,377,468.62, a decrease from CNY 1,782,639,595.43 at the beginning of the period, reflecting a decline of approximately 1.63%[94]. - Accounts receivable rose by 48.49% to 95.39 million yuan, attributed to slower customer payments due to the pandemic[45]. - The total assets decreased to CNY 2,487,202,803.66 from CNY 2,524,702,013.82, reflecting a decline of approximately 1.49%[95]. Market and Industry Impact - The decline in revenue was primarily due to the impact of the pandemic, particularly affecting the subsidiary engaged in hotel supplies, which was significantly impacted by the ongoing downturn in the tourism industry[18]. - The overall daily chemical industry is experiencing growth, with high-end products commanding higher profit margins, despite challenges posed by the pandemic and regulatory changes affecting the hotel supplies segment[30]. - The ongoing COVID-19 pandemic has negatively impacted the subsidiary Jiangsu Industrial Company, particularly in the tourism and hotel sectors[61]. - Rising prices of raw materials have increased procurement costs, adversely affecting the company's gross profit margins[61]. Research and Development - Research and development expenses increased by 28.75% to 5.91 million yuan, reflecting the company's commitment to new product development[41]. - The company maintains a strong research and development capability, holding proprietary technology for traditional Chinese medicine toothpaste and being recognized as a national high-tech enterprise[31]. - The company is actively exploring new sales models and product innovations to optimize its sales team and distributor network, with the subsidiary Fangcao Company reporting a revenue of 8.42 million yuan during the period[38]. Corporate Governance and Shareholder Information - The company has not proposed any profit distribution or capital reserve transfer plans for the half-year period[66]. - The total number of ordinary shareholders as of the end of the reporting period is 41,006[85]. - The largest shareholder, Guangxi Liuzhou Industrial Investment Development Group Co., Ltd., holds 183,360,652 shares, accounting for 33.34% of the total shares[87]. - The company has undergone changes in its board of directors, with the election of Sun Xuedong and the appointment of Gong Huiquan as president[65]. Environmental and Social Responsibility - The company has established an environmental protection leadership group to minimize the impact of its operations on the environment, aligning with national carbon neutrality policies[70]. - The company actively participates in rural revitalization efforts, providing support to Xindong Village, including sending a village secretary and conducting regular visits and assistance activities[72]. - The company has collaborated with the local ecological environment bureau to enhance monitoring systems for vehicle emissions, contributing to pollution prevention efforts[71].

Financial Performance - The company's operating revenue for Q1 2022 was ¥151,654,540.58, representing a decrease of 11.16% compared to the same period last year[4] - The net profit attributable to shareholders of the listed company was -¥29,554,814.23, indicating a significant loss[4] - The basic earnings per share for the period was -¥0.0537, indicating negative earnings performance[4] - The weighted average return on net assets was -1.39%, a decrease of 0.47 percentage points compared to the previous year[4] - The net profit for Q1 2022 was -29,687,617.70 RMB, compared to -19,367,116.54 RMB in Q1 2021, representing an increase in net loss of approximately 53.5% year-over-year[18] - Operating profit for Q1 2022 was -39,849,489.15 RMB, a decline from -31,888,321.06 RMB in the same period last year, indicating a worsening operational performance[18] - The total comprehensive income for Q1 2022 was -29,687,617.70 RMB, compared to -19,367,116.54 RMB in Q1 2021, showing a significant increase in comprehensive loss[19] Cash Flow and Liquidity - The net cash flow from operating activities was -¥25,841,425.42, reflecting ongoing cash flow challenges[4] - Cash and cash equivalents as of March 31, 2022, were CNY 1,156,945,464.89, a decrease from CNY 1,227,128,634.00 at the end of 2021, indicating liquidity challenges[13] - Cash flow from operating activities was -25,841,425.42 RMB in Q1 2022, an improvement from -47,369,585.48 RMB in Q1 2021, showing a reduction in cash outflow[21] - Cash and cash equivalents at the end of Q1 2022 stood at 1,155,292,756.38 RMB, compared to 571,938,830.76 RMB at the end of Q1 2021, indicating a significant increase in liquidity[22] - The company experienced a cash decrease of -70,222,913.68 RMB in Q1 2022, compared to -45,674,528.13 RMB in Q1 2021, indicating a worsening cash position[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,476,324,786.84, down 1.92% from the end of the previous year[5] - Total assets decreased to CNY 2,476,324,786.84 from CNY 2,524,702,013.82, reflecting a contraction in the asset base[16] - Total liabilities decreased to CNY 375,795,751.17 from CNY 394,485,360.45, indicating improved debt management[15] - The total equity attributable to shareholders decreased to CNY 2,106,078,801.44 from CNY 2,135,633,615.67, reflecting a decline in shareholder value[15] Operational Efficiency - The company reported a decrease in gross profit margin, which contributed to the decline in net profit[7] - Total operating costs for Q1 2022 were CNY 153,821,440.05, down from CNY 158,256,819.21 in Q1 2021, reflecting a cost reduction strategy[17] - Accounts receivable increased to CNY 86,435,501.01 from CNY 64,240,449.42, suggesting potential issues with collection or sales growth[13] - Inventory as of March 31, 2022, was CNY 191,156,704.36, slightly up from CNY 186,225,908.25, indicating stable inventory management[14] - The company reported a decrease in research and development expenses to CNY 2,990,829.12 from CNY 1,969,544.63, indicating a potential shift in focus or budget constraints[17] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 44,920[9] - The equity attributable to shareholders of the listed company decreased by 1.38% to ¥2,106,078,801.44[5]

Financial Performance - The company's operating revenue for 2021 was CNY 717.53 million, an increase of 4.68% compared to CNY 685.43 million in 2020[21] - The net profit attributable to shareholders for 2021 was CNY 8.66 million, a decrease of 85.08% from CNY 58.05 million in 2020[21] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 1.70 million, an increase of 79.86% compared to CNY 0.95 million in 2020[21] - The company's total assets at the end of 2021 were CNY 2.52 billion, a decrease of 1.27% from CNY 2.56 billion at the end of 2020[21] - The company reported a cash flow from operating activities of CNY -54.10 million in 2021, compared to CNY 15.79 million in 2020, indicating a significant decline[21] - The company's net assets attributable to shareholders at the end of 2021 were CNY 2.14 billion, a slight increase of 0.41% from CNY 2.13 billion at the end of 2020[21] - Basic earnings per share decreased by 85.12% to 0.0157 yuan per share compared to the previous year[23] - The weighted average return on equity fell to 0.41%, a decrease of 2.36 percentage points from the previous year[23] Revenue Breakdown - The operating income from the daily chemical segment reached CNY 142 million, with a focus on expanding online sales channels and optimizing marketing strategies[39] - Jiangsu Industrial Company reported an operating revenue of CNY 451 million, reflecting a growth of 5.76% year-on-year despite challenges in the hotel industry due to regional pandemic impacts[40] - Yikang Company generated an operating revenue of CNY 82.02 million, marking a 2.53% increase compared to the previous year, emphasizing the development of retail channels[43] - The revenue from daily chemical products reached ¥586.96 million, with a gross margin of 19.41%, down by 3.22 percentage points compared to the previous year[48] - The revenue from the pharmaceutical sector was ¥81.61 million, with a gross margin of 32.24%, down by 5.36 percentage points year-over-year[48] - The total revenue from online sales was ¥18.53 million, achieving a gross margin of 56.82%, which decreased by 5.02 percentage points year-over-year[48] - The total revenue from domestic operations was approximately ¥660.90 million, with a gross margin of 20.51%, down by 4.06 percentage points from the previous year[48] Research and Development - Research and development expenses amounted to CNY 11.74 million, showing a slight increase of 2.44% year-on-year, indicating ongoing investment in innovation[44] - The number of R&D personnel is 135, accounting for 9% of the total workforce[56] - The company is focused on R&D in traditional Chinese medicine, with two invention patents granted in 2021[72] Market and Competitive Landscape - The company has faced industry, market, and operational risks as detailed in the report[7] - The company faces increasing competition in the mature Chinese daily chemical industry, with intensified pressure from both domestic and imported products[96] - The ongoing COVID-19 pandemic has led to regional outbreaks, impacting subsidiaries like Jiangsu Industrial Company, particularly in the tourism and hotel sectors[96] Corporate Governance and Management - The company has established a strong governance structure with independent directors and a supervisory board in place[115] - The management team consists of experienced professionals with diverse backgrounds in finance, engineering, and management[115] - The company has maintained a stable shareholding structure, with no significant changes in the shareholdings of most directors and senior management during the reporting period[113] Strategic Initiatives - The company plans to use the undistributed profits for new product development, brand promotion, marketing investment, and supplementing daily working capital[5] - The strategic goal is to integrate daily chemical and pharmaceutical sectors to create a synergistic effect and drive growth[94] - The company aims to focus on product innovation and expand offline channels while optimizing online operations to enhance sales and brand influence in 2022[94] Social Responsibility - The company actively participated in social responsibility initiatives, including donating over 1 million yuan worth of products for flood relief efforts[151] - The company has successfully completed poverty alleviation tasks and is now focusing on rural revitalization efforts in targeted villages[153] - The company has established a quality education social practice base and promotes oral health knowledge to the public[152] Financial Management - The company has established a comprehensive internal control system that effectively ensures legal compliance, asset security, and the authenticity of financial reporting[143] - The company received a standard unqualified opinion in the internal control audit report for the 2021 financial report[145] - The total amount of guarantees provided by the company, excluding subsidiaries, was 2,500,000 RMB, which is 1.17% of the company's net assets[173] Employee Management - The total number of employees in the parent company and major subsidiaries is 1,509, with 466 in the parent company and 1,043 in subsidiaries[130] - The employee composition includes 859 production personnel, 128 sales personnel, 226 technical personnel, 44 financial personnel, 159 administrative personnel, and 93 others[130] - The company emphasizes a value-oriented compensation policy, where higher performance leads to higher pay[132]

Financial Performance - The company's operating revenue for Q3 2021 was ¥122,263,236.23, a decrease of 37.79% compared to the same period last year[3] - The net profit attributable to shareholders for Q3 2021 was ¥13,493,002.19, down 77.56% year-on-year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥5,241,078.00, a decrease of 60.44% compared to the same period last year[3] - The basic earnings per share for Q3 2021 was ¥0.0245, a decline of 77.58% year-on-year[4] - The net profit attributable to shareholders for the first three quarters was ¥2,880,151.80, down 95.39% year-on-year[3] - The net profit for the first three quarters of 2021 was CNY 2,887,223.18, a significant decrease from CNY 62,568,279.14 in the previous year, reflecting a decline of approximately 95.4%[18] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,505,435,788.94, a decrease of 1.95% from the end of the previous year[4] - As of September 30, 2021, the total current assets amounted to ¥1,764,477,655.47, a decrease from ¥1,812,151,935.33 at the end of 2020, reflecting a decline of approximately 2.03%[12] - The total assets of the company as of September 30, 2021, were ¥2,505,435,788.94, down from ¥2,555,266,114.09 at the end of 2020, indicating a decrease of approximately 1.95%[13] - The total liabilities decreased to ¥1,764,477,655.47 from ¥1,812,151,935.33, reflecting a decline of approximately 2.03%[13] - The company's total liabilities decreased to CNY 381,296,033.82 in Q3 2021 from CNY 434,013,582.15 in Q3 2020, showing a reduction of about 12.1%[18] - The total liabilities and equity amounted to CNY 2,505,435,788.94 in Q3 2021, a decrease from CNY 2,555,266,114.09 in Q3 2020, indicating a decline of approximately 1.95%[18] Cash Flow - The net cash flow from operating activities for the first three quarters was -¥63,270,870.92, indicating a significant cash outflow[3] - Net cash flow from operating activities was -63,270,870.92, compared to -16,022,254.16 in the previous year, indicating a decline in operational performance[21] - Total cash inflow from operating activities was 565,507,630.87, an increase from 531,466,338.52 year-over-year[21] - Total cash outflow from operating activities increased to 628,778,501.79 from 547,488,592.68, indicating higher operational costs[21] Investments and Expenses - The company reported a fair value change loss of ¥35,677,344.98 in its non-recurring gains and losses for the first three quarters[7] - Research and development expenses for the first three quarters of 2021 were CNY 7,652,735.71, slightly higher than CNY 7,130,435.23 in 2020, indicating an increase of approximately 7.3%[17] - The company reported an investment income of CNY 18,459,167.38 for the first three quarters of 2021, a significant increase from CNY 5,698,763.68 in the previous year, reflecting a growth of about 224.5%[17] Inventory and Receivables - The company's inventory increased to ¥178,303,948.97 from ¥148,432,611.28, marking a rise of about 19.99%[13] - The company’s other receivables decreased to ¥555,461,491.89 from ¥630,520,969.93, reflecting a decrease of about 11.91%[12] Cash and Equivalents - The company's cash and cash equivalents were reported at ¥639,062,882.53, an increase from ¥617,613,358.89 at the end of 2020, representing a growth of about 3.63%[12] - The ending balance of cash and cash equivalents was 636,216,179.00, compared to 566,160,218.54 at the end of the previous year[22] - The net increase in cash and cash equivalents was 23,695,639.74, contrasting with a decrease of 155,365,505.29 in the previous year[22] Financing Activities - Cash inflow from financing activities totaled 41,000,000.00, down from 53,000,000.00, indicating reduced borrowing[22] - Cash outflow from financing activities was 55,295,641.69, significantly lower than 222,992,991.63 in the previous year, leading to a net cash flow from financing activities of -14,295,641.69, compared to -169,992,991.63[22]

Financial Performance - The company achieved operating revenue of CNY 367.94 million in the first half of 2021, representing a 25.86% increase compared to the same period last year[18]. - The net profit attributable to shareholders of the listed company was a loss of CNY 10.61 million, compared to a profit of CNY 2.32 million in the same period last year[18]. - The net cash flow from operating activities was a negative CNY 39.03 million, worsening from a negative CNY 16.72 million in the previous year[18]. - The net assets attributable to shareholders of the listed company decreased by 0.50% to CNY 2.12 billion compared to the end of the previous year[18]. - Total assets decreased by 1.53% to CNY 2.52 billion compared to the end of the previous year[18]. - The basic earnings per share for the first half of 2021 was -CNY 0.0193, compared to CNY 0.0042 in the same period last year[19]. - The company reported a reduction in losses for the net profit attributable to shareholders after deducting non-recurring gains and losses, improving by CNY 7.63 million compared to the previous year[19]. - Operating revenue increased by 25.86% to RMB 367,938,649.46 compared to RMB 292,330,368.94 in the same period last year[38]. - Operating costs rose by 34.47% to RMB 283,392,979.91 from RMB 210,746,881.25 year-on-year[38]. - The company reported a significant decline in fair value changes, with losses of CNY 38,601,056.58 in the first half of 2021, compared to losses of CNY 10,330,937.50 in the same period last year[99]. - The total profit for the first half of 2021 was a loss of CNY 18,207,828.91, compared to a loss of CNY 264,317.10 in the same period last year[99]. Cost Management - The company continues to implement strict cost control measures to enhance efficiency and quality[19]. - The company reduced sales and management expenses by 32.22% and 12.81% respectively compared to the previous year[32]. - The company's management expenses decreased to CNY 31,650,748.70 in the first half of 2021 from CNY 32,947,227.73 in the previous year[99]. Cash Flow and Liquidity - The cash flow from financing activities improved to RMB 11,339,841.65 from RMB -172,457,458.30 in the previous year[38]. - The company’s cash and cash equivalents at the end of the reporting period were RMB 1,233,739.59, restricted as bank acceptance bill margin[41]. - The ending cash and cash equivalents balance as of June 30, 2021, was CNY 579,916,770.31, compared to CNY 565,709,192.71 at the end of June 2020[105]. - Cash received from sales of goods and services was CNY 370,505,241.77 in the first half of 2021, up from CNY 305,440,355.91 in the same period last year[104]. - Cash paid for goods and services in the first half of 2021 was CNY 294,645,040.43, compared to CNY 201,405,248.48 in the first half of 2020, indicating a significant increase in operational costs[104]. Market and Competition - The company faces intensified market competition in the daily chemical industry, with a stable market size and slow growth, necessitating a focus on R&D and brand positioning[55]. - The overall business environment improved as the domestic economy recovered from the pandemic, positively impacting the company's operations[31]. - The company is adapting to changes in channel structures due to the rise of online sales, aiming to expand into new emerging channels[56]. - The COVID-19 pandemic has created uncertainties affecting operations, particularly impacting the Jiangsu subsidiary due to declines in tourism and hotel industries[57]. Research and Development - The company has a strong R&D advantage, with proprietary technology in traditional Chinese medicine toothpaste and collaborations with several universities[27]. - Research and development expenses grew by 5.69% to RMB 4,592,828.01, up from RMB 4,345,370.12 in the previous year[38]. - The company plans to focus on improving operational efficiency to enhance profitability in the upcoming quarters[116]. Corporate Social Responsibility - The company actively engages in rural revitalization efforts, having successfully helped Pingxiu Village in Rongshui County achieve poverty alleviation status in 2020[67]. - During the reporting period, the company provided assistance to Xindong Village in Sanjiang County, including sending a village secretary to help consolidate poverty alleviation results[67]. - The company organized volunteer teams to visit and support villages, delivering relief supplies and funds to residents[67]. - In July 2021, the company donated over 40,000 boxes of disinfection products and more than 10,000 sets of personal care items valued at approximately 1 million yuan to support flood relief efforts in Henan[67]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 43,903[81]. - There were no changes in the total number of shares or the capital structure during the reporting period[80]. - The company has not proposed any profit distribution or capital reserve transfer plans for the first half of 2021[62]. Financial Position - The total equity attributable to the parent company at the end of the current period is 2,121,252,531.00, compared to 2,127,259,566.60 at the end of the previous period, reflecting a decrease of approximately 0.65%[111]. - The total comprehensive income for the current period is reported as -10,612,850.39, indicating a significant decline compared to the previous period's figures[113]. - The capital reserve stands at 1,184,901,870.00, unchanged from the previous period, indicating stability in this area[112]. - The retained earnings have decreased by 6,007,034.70, resulting in a total of 2,121,252,531.00 for the current period[111]. Accounting Policies - The company follows the accounting policies in accordance with the relevant enterprise accounting standards[130]. - The company applies the accounting treatment for business combinations under common control based on the book value of the acquired assets and liabilities as of the merger date[135]. - The company consolidates all subsidiaries under its control in the consolidated financial statements, reflecting the overall financial position and performance of the group[143].

1 证券代码：600249 证券简称：两面针 公告编号：临2021-008 柳州两面针股份有限公司 关于投资者网上集体接待日活动暨 2020 年度业绩说明会召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、 本次说明会召开情况 柳州两面针股份有限公司（以下简称"公司"）于 2021 年 5 月 21 日15:30-17:00 参加2021 年广西辖区上市公司投资者网上集体接待日活 动暨 2020 年度业绩说明会活动，公司董事长林钻煌先生，董事、副总 裁、财务总监王为民先生和董事会秘书韦元贤先生就公司 2020 年度的 公司治理、经营情况、战略发展等问题，与投资者进行了互动交流。 二、 投资者提出的主要问题及公司回复情况 1. 2021 年一季度，公司继续亏损，有哪些原因？ 回答：您好，感谢您对公司的关注。2020 年，公司顶住疫情考验 和市场竞争的双重压力，扣非净利润多年来首次实现盈利，且现金流健 康。2021 年公司一季报显示，公司营业收入同比增长 24.72%，净利润 亏损主要由于公司持有的交易性金 ...

1 证券代码：600249 证券简称：两面针 公告编号：临2021-007 柳州两面针股份有限公司 关于参加投资者网上集体接待日活动暨 2020 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 会议召开时间：2021 年 5 月 21 日（星期五）15:30-17:00。 ● 会议召开方式：网络在线问答互动形式。 ● 会议召开地点："全景•投资者关系互动平台"（http://ir.p5w.net）。 一、 会议类型 柳州两面针股份有限公司（以下简称"公司"）已于 2021 年 3 月 31 日在上海 证券交易所（www.sse.com.cn）披露了公司《2020 年年度报告》。为进一步加强与 投资者的互动交流，公司将参加由广西上市公司协会、深圳市全景网络有限公司共 同举办的"2021 年广西地区上市公司投资者网上集体接待日活动暨 2020 年度业绩 说明会"。 二、 会议召开的时间、方式 1.召开时间：2021 年 5 月 21 日（星期五）15:30-17:00。 2.召开方式 ...

Financial Performance - Operating revenue increased by 24.72% to CNY 170,712,167.79 compared to the same period last year[5] - Net profit attributable to shareholders of the listed company was a loss of CNY 19,394,838.64, compared to a loss of CNY 17,566,948.54 in the previous year[5] - The net profit after deducting non-recurring gains and losses was CNY 5,393,130.10, a significant improvement from a loss of CNY 4,339,249.79 in the same period last year[5] - Other income increased significantly by 1012.23% to CNY 3,105,391.85 primarily due to increased government subsidies received[12] - Investment income rose by 2069.61% to CNY 242,207.54 mainly from increased financial investment returns[12] - Operating income increased by 237.52% to CNY 1,355,057.44 driven by higher government subsidies[13] - The company reported a decrease in sales expenses to ¥7,871,486.27 in Q1 2021 from ¥13,646,751.48 in Q1 2020, a reduction of approximately 42.0%[30] - The company recorded other income of ¥1,355,057.44 in Q1 2021, up from ¥401,479.71 in Q1 2020, indicating improved non-operating income[29] Cash Flow - The net cash flow from operating activities was a negative CNY 47,369,585.48, worsening from a negative CNY 34,076,302.85 in the previous year[5] - Net cash flow from operating activities decreased to CNY -47,369,585.48, a decline of CNY 13,293,282.63 compared to the previous year[16] - The cash flow from operating activities for Q1 2021 was -¥47,369,585.48, compared to -¥34,076,302.85 in Q1 2020, reflecting increased cash outflow[34] - The net cash flow from operating activities for Q1 2021 was -2,786,330.43 RMB, an improvement from -8,238,042.31 RMB in Q1 2020[36] - Total cash inflow from operating activities was 43,101,880.08 RMB, compared to 41,306,331.97 RMB in the same period last year, reflecting a growth of approximately 4.34%[36] - Cash outflow from operating activities decreased to 45,888,210.51 RMB from 49,544,374.28 RMB year-over-year, indicating a reduction of about 7.4%[36] - The company reported a cash flow net decrease of -4,623,283.12 RMB for the quarter, an improvement from -107,843,455.13 RMB in Q1 2020[37] Assets and Liabilities - Total assets decreased by 3.13% to CNY 2,475,287,115.78 compared to the end of the previous year[5] - Total assets decreased to CNY 2,475,287,115.78 from CNY 2,555,266,114.09, reflecting a reduction in current assets[22] - Total liabilities decreased to CNY 373,401,700.38 from CNY 434,013,582.15, indicating a reduction in financial obligations[22] - Total liabilities as of March 31, 2021, were CNY 172,350,977.92, down from CNY 197,112,164.31 at the end of 2020[25] - The company’s total equity as of March 31, 2021, was CNY 2,020,861,714.00, down from CNY 2,042,304,145.02 at the end of 2020[25] Shareholder Information - The number of shareholders reached 45,462 at the end of the reporting period[9] - The top shareholder, Guangxi Liuzhou Industrial Investment Development Group Co., Ltd., holds 33.34% of the shares[9] Research and Development - Research and development expenses for Q1 2021 were CNY 1,969,544.63, a decrease from CNY 2,123,346.28 in Q1 2020[27] - Research and development expenses increased slightly to ¥1,344,712.84 in Q1 2021 from ¥1,240,843.65 in Q1 2020, showing a focus on innovation[30] Other Financial Metrics - The weighted average return on net assets decreased by 0.07 percentage points to -0.92%[5] - Non-recurring gains and losses totaled a negative CNY 24,787,968.74 for the period[7] - Cash and cash equivalents as of March 31, 2021, were CNY 510,877,295.36, slightly down from CNY 515,500,578.48 at the end of 2020[23] - The company has not disclosed any new product developments or market expansion strategies in this report[10]

Financial Performance - The company's operating revenue for 2020 was approximately ¥685.43 million, a decrease of 42.24% compared to ¥1.19 billion in 2019[21]. - The net profit attributable to shareholders for 2020 was approximately ¥58.01 million, a significant recovery from a loss of ¥53.81 million in 2019[22]. - The net profit after deducting non-recurring gains and losses was approximately ¥902,077.21, compared to a loss of ¥119.50 million in the previous year[22]. - The company's total assets at the end of 2020 were approximately ¥2.56 billion, a decrease of 5.14% from ¥2.69 billion at the end of 2019[22]. - The net cash flow from operating activities for 2020 was approximately ¥14.87 million, a decline of 83.26% from ¥88.80 million in 2019[22]. - The company's net assets attributable to shareholders increased by 2.84% to approximately ¥2.13 billion at the end of 2020, compared to ¥2.07 billion at the end of 2019[22]. - Basic earnings per share for 2020 was CNY 0.1055, a recovery from a loss of CNY 0.10 in 2019[24]. - The weighted average return on equity for 2020 was 2.76%, improving from -3.04% in 2019[24]. - The company reported a significant decrease in sales expenses by 36.68% to ¥103.74 million, and management expenses decreased by 17.3% to ¥61.92 million[56]. - The total operating revenue for 2020 was ¥685,431,238.99, a decrease of approximately 42.3% compared to ¥1,186,674,091.12 in 2019[189]. - The company's gross profit margin improved, with gross profit for 2020 at ¥169,924,920.25, compared to a gross loss in 2019[189]. Strategic Focus - The company decided not to distribute profits for 2020, opting to reinvest the retained earnings into new product development and marketing efforts[5]. - The company is focusing on sustainable high-quality development despite previous years' losses, indicating a strategic shift towards long-term growth[5]. - The company plans to continue focusing on market expansion and new product development to enhance future performance[30]. - The company aims to focus on the integration of traditional Chinese medicine and daily chemicals, enhancing consumer quality of life through innovation[90]. - In 2021, the company plans to prioritize "market expansion and cost control," emphasizing "efficiency first while considering scale" in its operations[91]. Risk Management - The company has outlined potential risks in its future development, including industry and market risks[8]. - The company faces risks from intensified market competition, with the daily chemical industry entering a mature phase and experiencing slow growth[93]. - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[7]. Corporate Governance - The company has established a complete corporate governance structure and improved information disclosure quality, receiving a good evaluation for its disclosure work during the reporting period[119]. - The company has made commitments to ensure independence and avoid competition with its controlling shareholders and related parties[104]. - The company has not proposed any capital reserve transfer to increase share capital in the last three years[100]. - The company has not faced any penalties from securities regulatory agencies in the past three years, indicating a stable compliance record[142]. - The company has established a robust internal control system, ensuring effective operation and legal compliance in decision-making processes[119]. Social Responsibility - The company actively participated in pandemic relief efforts, donating over 3 million RMB in cash and materials to support frontline workers and local communities[119]. - The company has successfully helped the designated poverty alleviation village, Peixiu Village, achieve poverty alleviation status during the reporting period[119]. - The company has implemented a comprehensive environmental management system, ensuring compliance with local pollution discharge regulations and obtaining the national pollution discharge permit valid until March 9, 2025[120]. - The company has actively promoted oral health knowledge through its museum and public outreach initiatives, enhancing scientific literacy in the community[119]. Employee Management - The total number of employees in the parent company and major subsidiaries is 1,506, with 499 in the parent company and 1,007 in subsidiaries[143]. - The company has established a performance evaluation management system to enhance its incentive system, emphasizing value orientation where higher performance leads to higher compensation[144]. - The company has a training program aimed at improving employee skills and ensuring a sustainable talent pool for future growth[146]. - The total number of employees with postgraduate degrees is 33, while those with a bachelor's degree number 303[143]. Financial Position - The company maintained a stable capital structure with total equity of ¥2,121,252,531.94 in 2020 compared to ¥2,062,333,918.15 in 2019[183]. - The company reported a year-end undistributed profit of RMB 69,570.69 million for 2020, following a net profit increase of RMB 5,322.40 million[98]. - The company’s financial report indicates a focus on improving operational efficiency and reducing liabilities in the upcoming fiscal year[180]. - Total current assets decreased from ¥1,924,846,831.74 in 2019 to ¥1,812,151,935.33 in 2020, a decline of approximately 5.8%[181]. Shareholder Information - The largest shareholder, Guangxi Liuzhou Industrial Investment Development Group Co., Ltd., holds 183,360,652 shares, representing 33.34% of the total shares[126]. - The company has no other significant shareholders with more than 10% ownership[131]. - The actual controller of the company is the Liuzhou Municipal Government State-owned Assets Supervision and Administration Commission[131]. - The company has no reported changes in the controlling shareholder during the reporting period[130].

Financial Performance - Operating revenue for the first nine months was CNY 488,866,614.02, a decline of 44.56% year-on-year[6] - Net profit attributable to shareholders increased by 700.63% to CNY 62,437,646.56 compared to the same period last year[6] - Revenue decreased by 20.50% compared to the same period last year when excluding the impact of divested paper and real estate businesses[8] - The company reported a net profit of CNY 5,165,417.40 after deducting non-recurring gains and losses, compared to a loss of CNY 43,433,720.76 in the previous year[8] - The company's operating revenue decreased by 90.72% to CNY 108,332.95, primarily due to a decline in sales volume caused by the pandemic and the exclusion of paper and real estate companies from the consolidated scope[19] - Q3 2020 net profit was CNY 60,603,734.82, a decrease of 34.2% compared to Q3 2019's CNY 62,568,279.14[33] - Total revenue for Q3 2020 was CNY 50,286,253.23, a slight increase of 2.0% from CNY 49,290,783.69 in Q3 2019[35] - The company reported a total profit of CNY 75,433,774.19 for Q3 2020, a decrease of 30.5% from CNY 108,591,721.67 in Q3 2019[33] Cash Flow and Liquidity - Cash flow from operating activities showed a net outflow of CNY 16,022,254.16, compared to a net inflow of CNY 36,578,872.78 in the previous year[6] - The net cash flow from operating activities was negative CNY 16,022,254.16, a decrease of CNY 52,601,126.94 compared to the same period last year, attributed to reduced cash receipts from sales and the exclusion of certain companies from consolidation[20] - The net cash flow from financing activities decreased by 220.23% to negative CNY 169,992,991.63, mainly due to significant loan repayments during the period[20] - The ending cash and cash equivalents balance as of September 30, 2020, was CNY 566.16 million, down from CNY 721.53 million at the beginning of the year[40] - The company incurred cash outflows of CNY 547.49 million from operating activities in the first three quarters of 2020, a decrease of 42.5% from CNY 950.85 million in the same period of 2019[39] Assets and Liabilities - Total assets decreased by 6.85% to CNY 2,509,121,430.33 compared to the end of the previous year[6] - The total number of shareholders at the end of the reporting period was 46,784[12] - The company's total liabilities decreased from CNY 631,264,328.03 to CNY 383,487,233.04, indicating improved financial stability[27] - Current liabilities decreased from CNY 571,629,509.12 to CNY 315,103,465.91, reflecting a reduction in short-term borrowings and other payables[26] - The company's cash and cash equivalents decreased from CNY 724,026,773.82 to CNY 566,457,935.00, reflecting a tighter liquidity position[25] - Total current assets amounted to CNY 1,924,846,831.74, with cash and cash equivalents at CNY 724,026,773.82 and trading financial assets at CNY 253,264,543.61[45] Shareholder Equity and Restructuring - The weighted average return on equity rose by 0.43 percentage points to 2.97%[6] - Basic earnings per share increased by 699.30% to CNY 0.1135[6] - The capital reserve increased to ¥1,184,901,870.95, an increase of ¥327,503,100.99, or 38.20% compared to the previous year[16] - The company completed significant asset restructuring in 2019, which impacted the current financial results[8] - The company completed the transfer of 84.62% equity in the paper company and 80% equity in the real estate company to its largest shareholder, which will impact future financial performance[21] Expenses and Costs - Operating costs decreased to ¥354,392,187.86, a reduction of ¥374,228,775.11, or 51.36% year-over-year[18] - The company reported a substantial reduction in management expenses, which fell to ¥47,007,531.33, a decrease of ¥28,992,475.25, or 38.15% year-over-year[18] - The income tax expense decreased by 33.85% to CNY 12,601,177.95, resulting from a reduction in fair value changes of stocks compared to the same period last year[19] - Financial expenses for Q3 2020 were CNY -11,025,037.25, a significant improvement from CNY -22,175,695.27 in Q3 2019[36] Future Outlook - The company does not anticipate significant changes in net profit for the upcoming reporting period compared to the previous year[23] - The company plans to continue focusing on R&D and market expansion to drive future growth[36]